News
The FDA has approved Lenacapavir a drug touted to be 999 effective in preventing HIV But it remains inaccessible for Indians ...
The FDA has approved Yeztugo for PrEP to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35kg.
National Aids Commission (NAC) and health campaigners have welcomed the approval of a twice-a-year HIV prevention injection ...
While PrEP tablets are already prescribed around the world to prevent people from contracting HIV, experts in the US hope a newly approved jab could improve rates of protection.
12hOpinion
The Daily Monitor on MSNDo not drop the guard on HIV /Aids fightWhereas the new HIV prevention drug, Lenacapavir, is a positive step towards HIV prevention, its cost is prohibitive. The ...
StockStory.org on MSN14h
5 Insightful Analyst Questions From Gilead Sciences’s Q1 Earnings CallGilead Sciences’ first quarter performance saw sales remain flat year over year, which did not meet Wall Street’s revenue ...
A recent study revealed that weed is linked with a doubled mortality risk from cardiac diseases. The study further discovered ...
The 'sitting-rising test' is a non-aerobic fitness assessment of the muscle strength, flexibility, balance, and body composition of an individual ...
India denies fake claims of US using its airspace for Iran strikes. PIB Fact Check confirms no Indian airspace was used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results